Money

Novo Nordisk stock surges 7% after Ozempic maker’s latest weight loss drug shows promise

Photo of Oklahoma Digital News Oklahoma Digital NewsJanuary 24, 2025
Less than a minute



The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger. Read More


Source link

Photo of Oklahoma Digital News Oklahoma Digital NewsJanuary 24, 2025
Less than a minute
Photo of Oklahoma Digital News

Oklahoma Digital News

Related Articles

Trump set to sign Laken Riley Act mandating detention of migrants accused of theft and violent crimes as his first piece of legislation

January 29, 2025

How high rates and high prices are contributing to low existing home sales

January 29, 2025

Lithuania is the world’s happiest country for young people. Here’s what it’s like to work for the country’s leading tech unicorn

January 29, 2025

Donald Trump says he wants a bidding war for TikTok and wouldn’t mind if Microsoft won

January 29, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *